๐ฐ Georges News
Page 3 - Georges News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Georges. Real-time updates on events, politics, business and more.
May 9, 2023
Doctors at the King Georges Medical University (KGMU) in Lucknow have come across one such case of a middle-aged man who developed cancer. Such a condition is reported once in 5-10 years, said a doctor treating the patient at the King Georges Medical University.
May 4, 2023
MONTRÉAL, QC / ACCESSWIRE / May 4, 2023 / St-Georges Eco-Mining Corp. (CSE:SX)(OTCQB:SXOOF)(FSE:85G1) is pleased to report the completion of an important milestone in the preparation of its proposed lithium
April 25, 2023
Acclaimed pianist Katherine Austin and successful cellist Hyein Kim to perform on May 7.
April 24, 2023
MONTRÉAL, QC / ACCESSWIRE / April 24, 2023 / St-Georges Eco-Mining Corp. (CSE:SX)(OTCQB:SXOOF)(FSE:85G1) is pleased to announce the initial assay results from samples derived from its metallurgical sampling
April 18, 2023
Thames Citizensโ Band directed by Linden Moyle who play on April 28 at St Georgeโs
April 5, 2023
CRYTEL MAURITIUS LIMITED 24 St. Georges Street, Port Louis, Mauritius NON-PUBLICATION OF THE AUDITED FINANCIAL... | April 5, 2023
April 1, 2023
Should be pretty explosive. whats been reported is that the main charge here is around the more direct transaction that didnt involve me from michael cohen. just stormy daniels. now weve also learned in recent days that not only did david pecker the head of am i testified twice before this grand jury, but jurors heard detailed evidence about the karen macdougal situation about that transaction. thats really significant anderson because it means theyre not just looking at one relatively small hus...
March 28, 2023
Telegraph: Exercise and new techniques can help, experts say.
March 24, 2023
James Brown is looking forward to performing in his beloved Thames.
March 24, 2023
Regulatory News: Celyad Oncology (Euronext Nasdaq: CYAD) (the "Company"), a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, is pleased